| Current Price | $0.50 | Mkt Cap | $24.5M |
|---|---|---|---|
| Open | $0.48 | P/E Ratio | -1.17 |
| Prev. Close | $0.50 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $0.47 - $0.51 | Volume | 226 |
| 52-Wk Range | $0.29 - $0.84 | Avg. Daily Vol. | 128,421 |
A biopharmaceutical company engaged in the clinical development, manufacture, marketing and distribution of new drug entities based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders.
| Current Price | $0.50 | Mkt Cap | $24.5M |
|---|---|---|---|
| Open | $0.48 | P/E Ratio | -1.17 |
| Prev. Close | $0.50 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $0.47 - $0.51 | Volume | 226 |
| 52-Wk Range | $0.29 - $0.84 | Avg. Daily Vol. | 128,421 |
The best Bull and Bear pitches based on recency and number of recommendations.
Gonna surprise everyone with an advisory committee panel that votes in favor of accelerated approval with phase 4 trials being required.
Ok where should I start?To my knowledge:The company burns more then 4 mil $$$ each quarter.They have just couple products.Ampligen®Alferon LDO®which have high side effects chance and at best they can sell those products for 6milThey have couple more… More
Read the most recent pitches from players about AIM.
Recs
rtovar
(< 20)
Submitted: 6/8/2020 5:59:32 PM :
Start Price:
$2.60
NYSE MKT:AIM Score:
-122.84
I've followed this company carefully. Their flagship product has been proven to work on SARS, and should be effective against Corvid19. The fact that they have trials in the US and China is a plus.
Recs
SpartyFool
(< 20)
Submitted: 5/30/2020 1:06:20 PM :
Start Price:
$2.77
NYSE MKT:AIM Score:
-131.63
Will take off as 5G escalates.
Recs
OklaBoston
(34.36)
Submitted: 3/1/2020 10:30:45 AM :
Start Price:
$2.30
NYSE MKT:AIM Score:
-135.69
Shrinking deficit and being in a high growth industry.
Find the members with the highest scoring picks in AIM.
RetestingLows (28.31) Score: +514.58
The Score Leader is the player with the highest score across all their picks in AIM.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| RetestingLows | 28.31 | 7/9/2009 |
|
5Y | $25.56 | -98.04% | +416.55% | +514.58 | 0 Comment | |
| thestockstalker | < 20 | 5/21/2009 |
|
NS | $21.60 | -97.68% | +413.64% | +511.31 | 0 Comment | |
| marginaddict | < 20 | 6/23/2009 |
|
3W | $25.56 | -98.04% | +410.68% | +508.72 | 3 Comments | |
| soul2197 | 98.23 | 6/25/2009 |
|
3W | $22.68 | -97.79% | +409.58% | +507.37 | 0 Comment | |
| ehabob | 56.02 | 5/28/2009 |
|
3M | $20.64 | -97.57% | +405.06% | +502.63 | 0 Comment | |
| Hero4All | 27.99 | 5/20/2009 |
|
5Y | $21.36 | -97.65% | +400.85% | +498.50 | 0 Comment | |
| GingerBean | < 20 | 6/26/2009 |
|
5Y | $28.32 | -98.23% | +397.93% | +496.16 | 0 Comment | |
| raambo | < 20 | 6/3/2009 |
|
3W | $30.24 | -98.34% | +394.59% | +492.93 | 0 Comment | |
| avatre | < 20 | 6/8/2009 |
|
5Y | $35.88 | -98.60% | +389.66% | +488.26 | 0 Comment | |
| epc53 | 79.52 | 6/1/2009 |
|
5Y | $21.00 | -97.61% | +390.56% | +488.17 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
